home / stock / dh / dh news


DH News and Press, Definitive Healthcare Corp. From 08/31/22

Stock Information

Company Name: Definitive Healthcare Corp.
Stock Symbol: DH
Market: NASDAQ
Website: definitivehc.com

Menu

DH DH Quote DH Short DH News DH Articles DH Message Board
Get DH Alerts

News, Short Squeeze, Breakout and More Instantly...

DH - Definitive Healthcare Grows Headcount Despite Gathering Recession Clouds

Summary Definitive Healthcare went public in September 2021, raising around $420 million in a U.S. IPO. The firm provides healthcare and pharmaceutical companies with a wide range of data and analytics software products. DH is starting to see lengthening sales cycles and is pr...

DH - Baron Discovery Fund Q2 2022 Shareholder Letter

Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. In the second quarter, the Baron Discovery Fund was down 22.66% (Institutional Shares), which was 3.41% below the Russell...

DH - Definitive Healthcare Corp (DH) CEO Robert Musslewhite on Q2 2022 Results - Earnings Call Transcript

Definitive Healthcare Corp (DH) Q2 2022 Earnings Conference Call August 04, 2022, 17:00 ET Company Participants David Samuels - Chief Legal Officer Robert Musslewhite - President, CEO & Director Jason Krantz - Founder & Executive Chairman Richard Boot...

DH - Definitive Healthcare Corp. (DH) Q2 2022 Earnings Call Transcript

Image source: The Motley Fool. Definitive Healthcare Corp. (NASDAQ: DH) Q2 2022 Earnings Call Aug 04, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Definitive Healthcare Corp. (DH) Q2 2022 Earnings Call Transcript...

DH - Allied Healthcare, Progyny top healthcare gainers; Quoin, Helius lead losers' pack

Gainers: Allied Healthcare Products ( AHPI ) +30% . Progyny ( PGNY ) +28% . Kazia Therapeutics ( KZIA ) +21% . Selecta Biosciences ( SELB ) +18% . Sensus Healthcare ( SRTS ) +17% . Losers: Quoin Pharmaceuticals ( QNRX...

DH - Definitive Healthcare GAAP EPS of -$0.05 beats by $0.03, revenue of $54.5M beats by $0.87M

Definitive Healthcare press release ( NASDAQ: DH ): Q2 GAAP EPS of -$0.05 beats by $0.03 . Revenue of $54.5M (+36.9% Y/Y) beats by $0.87M . Based on information as of August 4, 2022, the Company is issuing the following financial guidance.  Third Qu...

DH - Definitive Healthcare Reports Financial Results for Second Quarter Fiscal Year 2022

FRAMINGHAM, Mass., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter ended June 30, 2022. Second Quarter 2022...

DH - Definitive Healthcare to Present at the Canaccord Genuity 42nd Annual Growth Conference

FRAMINGHAM, Mass., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that its Founder and Executive Chairman, Jason Krantz, its Chief Executive Officer...

DH - Definitive Healthcare launches Passport Express to provide ready-to-use healthcare commercial intelligence for biopharma

FRAMINGHAM, Mass., July 26, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH ), an industry leader in healthcare commercial intelligence, today announced the general availability of Passport Express , the newest product in the Passport Analytics Suite . B...

DH - ClearBridge Select Strategy Portfolio Manager Commentary Q2 2022

Exposure to disruptors in areas of the market that have derated after a surge in demand during the pandemic, namely consumer technology and e-commerce, weighed on performance in a difficult quarter for higher growth stocks. We were active during the quarter, tactically pivoting the po...

Previous 10 Next 10